Genetic study of drug transporter

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0000547

Enrollment

700

Registered

2012-09-29

Start date

2003-09-30

Completion date

Unknown

Last updated

2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : Blood sampling, Carbamazepine oral administration for epilepsy treatment 200~600mg/day

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Epilepsy patients with carbamazepine

Exclusion criteria

Exclusion criteria: Refractory epilepsy patients Non cooperated patients

Design outcomes

Primary

Measure	Time frame
CNS Adverse drug events;Drug transporter genotype analysis	—

Secondary

Measure	Time frame
Treatment response of carbamazepine	—

Countries

Korea, Republic of

Contacts

Public ContactHyung Soon Park

Yonsei University

Outcome results